J. Hermida

发表

In Vitro and In Vivo Down-Regulation of Regulatory T Cell Activity with a Peptide Inhibitor of TGF-β11

J. Prieto, S. V. van Deventer, J. Lasarte, 2008, The Journal of Immunology.

Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients

W. Parks, M. Toni, E. Toledo, 2013, Diabetologia.

High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients

J. Paramo, S. Schulman, I. Gil-Bazo, 2013, Thrombosis and Haemostasis.

Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation

B. Dahlbäck, A. Villegas-Méndez, P. Simioni, 2004, The FEBS journal.

Is EPCR a multi-ligand receptor? Pros and cons

J. Hermida, R. Montes, C. Puy, 2012, Thrombosis and Haemostasis.

The endothelial cell protein C receptor: its role in thrombosis.

F. España, A. Estellés, J. Hermida, 2011, Thrombosis research.

Inhibitor of TGF-Regulatory T Cell Activity with a Peptide In Vitro and In Vivo Down-Regulation of Borrás

J. Prieto, S. V. Deventer, J. Lasarte, 2008 .

Tumor necrosis factor-alpha inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock.

A. Matsukawa, H. Nariuchi, M. Montes, 2003, The Journal of laboratory and clinical medicine.

Interleukin (IL)-8 and growth related oncogene-α in severe endotoxemia and the effects of a tumor necrosis factor-α/IL-1β inhibitor on these chemokines

A. Matsukawa, M. Montes, J. Hermida, 2002 .

Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury.

P. Walsh, J. Orbe, J. Hermida, 2015, Blood.

THROMBOSIS AND HEMOSTASIS Activated protein C b-glycoform promotes enhanced noncanonical PAR 1 proteolysis and superior resistance to ischemic injury

G. Dichiara, P. Walsh, J. Orbe, 2015 .

Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo

K. Fukudome, J. López-Sagaseta, J. Hermida, 2010, Thrombosis and Haemostasis.

VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A

M. Larrayoz, A. Calvo, R. Catena, 2010, Molecular Cancer.

Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis

F. Rosendaal, A. van Hylckama Vlieg, J. Hermida, 2007, Journal of thrombosis and haemostasis : JTH.

[Role of CFH and ARMS2 polymorphisms in retinopathy and coronary artery disease in type 1 diabetes].

M. Toni, E. Toledo, J. Hermida, 2012, Anales del sistema sanitario de Navarra.

Laparoscopic limited liver resection decreases morbidity irrespective of the hepatic segment resected.

F. Rotellar, A. Benito, J. Hermida, 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage

J. Oyarzábal, A. Pineda-Lucena, J. Paramo, 2022, Thrombosis and haemostasis.

J. Hermida, R. Montes, Eduardo Rocha, 2012 .

The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients

Á. Alonso, J. Hermida, R. Montes, 2008, British journal of haematology.

Leu208Val and Ile181Leu variants of cytochrome P450 CYP2C9 are not related to the acenocoumarol dose requirement in a Spanish population.

J. Hermida, R. Montes, Eduardo Rocha, 2002, Blood.

Prevention of Renal Fibrin Deposition in Endotoxin-induced DIC through Inhibition of PAI-1

M. Muñoz, P. Declerck, E. Rocha, 2000, Thrombosis and Haemostasis.

Association of increased fibrinogen concentration with impaired activation of anticoagulant protein C

F. España, Á. Alonso, Á. Alonso, 2006, Journal of thrombosis and haemostasis : JTH.

sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove.

C. Esmon, J. López-Sagaseta, J. Hermida, 2012, Blood.

In Vitro and In Vivo Down-Regulation of Regulatory T Cell Activity with a Peptide Inhibitor of TGF- 1

J. Lasarte, J. Riezu-Boj, P. Sarobe, 2008 .

Regulation by Nitric Oxide of Endotoxin-Induced Tissue Factor and Plasminogen Activator Inhibitor-1 in Endothelial Cells

J. Paramo, F. Velasco, C. López-Pedrera, 2002, Thrombosis and Haemostasis.

Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study.

J. Paramo, I. Gil-Bazo, J. López-Picazo, 2015, Thrombosis research.

Effect of the administration of recombinant hirudin and/or tissue‐plasminogen activator (t‐PA) on endotoxin‐induced disseminated intravascular coagulation model in rabbits

J. Paramo, E. Rocha, M. Muñoz, 1999, British journal of haematology.

The c.−1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients

M. Martínez-González, J. Hermida, R. Montes, 2006, British journal of haematology.

Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library.

J. Prieto, J. Lasarte, J. Riezu-Boj, 2007, Cytokine.

Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality.

J. Paramo, E. Rocha, J. Hermida, 1998, The Journal of laboratory and clinical medicine.

Haemostatic Genetic Risk Factors in Arterial Thrombosis

S. Rezende, D. Lane, J. Hermida, 2001, Thrombosis and Haemostasis.

Losartan Metabolite EXP3179 Blocks NADPH Oxidase-Mediated Superoxide Production by Inhibiting Protein Kinase C: Potential Clinical Implications in Hypertension

G. Zalba, J. López-Sagaseta, J. Hermida, 2009, Hypertension.

Activated protein C: reasons to believe

J. Hermida, J. Díez, R. Montes, 2012, Journal of thrombosis and haemostasis : JTH.

Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death.

J. Gris, M. Khamashta, M. Martínez-González, 2004, Blood.

Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin‐induced disseminated intravascular coagulation in rabbits

M. Muñoz, J. Paramo, E. Rocha, 1999, American journal of hematology.

Contribution of cytokines to hyperfibrinolysis during orthotopic liver transplantation and effect of aprotinin

J. Paramo, E. Rocha, J. Hermida, 1996 .

Interleukin (IL)-8 and growth related oncogene-alpha in severe endotoxemia and the effects of a tumor necrosis factor-alpha/IL-1beta inhibitor on these chemokines.

A. Matsukawa, M. Montes, J. Hermida, 2002, Experimental and molecular pathology.

Genetic predisposition to bleeding during treatment oral anticoagulants treatment

J. Hermida, R. Montes, J. Zozaya, 2008 .

Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk.

O. Rabal, J. Oyarzábal, J. González-Porras, 2016, Cardiovascular research.

Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant

T. Theander, M. Stins, L. Turner, 2015, Thrombosis and Haemostasis.

Group V secretory phospholipase A2 impairs endothelial protein C receptor‐dependent protein C activation and accelerates thrombosis in vivo

C. Esmon, J. Hermida, R. Montes, 2014, Journal of thrombosis and haemostasis : JTH.

Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity

K. Fukudome, J. López-Sagaseta, J. Hermida, 2007, Journal of thrombosis and haemostasis : JTH.

Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

Mar Marcos, J. Paramo, I. Gil-Bazo, 2019, TH Open.

Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience

I. Gil-Bazo, J. López-Picazo, R. Lecumberri, 2018, Clinical and Translational Oncology.

Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study

J. Paramo, I. Gil-Bazo, J. López-Picazo, 2018, PloS one.

Poor Relationship between Phenotypes of Protein S Deficiency and Mutations in the Protein S Alpha Gene

P. Mannucci, E. Faioni, J. Hermida, 1999, Thrombosis and Haemostasis.

Short Leukocyte Telomere Length Is Associated With Cardioembolic Stroke Risk in Patients With Atrial Fibrillation

J. González-Porras, R. Lecumberri, E. Toledo, 2016, Stroke.

Leukocyte Telomere Length Is Associated With Cardioembolic Stroke Risk in Patients With Atrial Fibrillation

J. González-Porras, R. Lecumberri, E. Toledo, 2016 .

Plasma Thrombomodulin Is Increased in Cord Blood of Healthy Newborns

J. Paramo, E. Rocha, J. Hermida, 1995, Thrombosis and Haemostasis.

Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.

I. Wistuba, F. Lecanda, M. Pajares, 2012, American journal of respiratory and critical care medicine.

The Endotoxin-induced Plasminogen Activator Inhibitor-1 Increase in Rabbits Is Not Tumor Necrosis Factor-α Dependent and Can Occur in the Absence of Interleukin-1β

A. Matsukawa, J. Hermida, R. Montes, 2002, Thrombosis and Haemostasis.

Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women

P. Mannucci, L. Foco, Á. Alonso, 2005, Journal of thrombosis and haemostasis : JTH.

Phenotype : A Role in Cardioembolic Stroke ? Limited Ability to Activate Protein C Confers Left Atrial

C. Esmon, F. España, J. Hermida, 2011 .

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

R. Gomis, S. Vicent, F. Lecanda, 2017, Journal of Hematology & Oncology.

Inducing heat shock protein 70 expression provides a robust anti-thrombotic effect with minimal bleeding risk

J. Oyarzábal, E. Guruceaga, R. Lecumberri, 2017, Thrombosis and Haemostasis.

Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study

J. González-Porras, J. Paramo, R. Lecumberri, 2016, European journal of haematology.

Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study).

B. Astor, K. Matsushita, Á. Alonso, 2012, The American journal of cardiology.

Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol.

J. Hermida, R. Montes, E. Molina, 2002, Blood.

CYP2C9 on sensitivity to acenocoumarol Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450

J. Hermida, R. Montes, E. Molina, 2012 .

Atrial fibrillation in pigs induces left atrial endocardial transcriptional remodelling

V. Segura, J. Gavira, A. Macías, 2012, Thrombosis and Haemostasis.

The endothelial cells downregulate the generation of factor VIIa through EPCR binding

J. López-Sagaseta, J. Hermida, R. Montes, 2010, British journal of haematology.

The functional properties of a truncated form of endothelial cell protein C receptor generated by alternative splicing

J. López-Sagaseta, J. Hermida, R. Montes, 2008, Haematologica.

[Indications for bone marrow transplantation].

J. Rifón, J. Hermida, C. Panizo, 1994, Revista de medicina de la Universidad de Navarra.

Losartan Metabolite EXP3179 Blocks NADPH Oxidase-Mediated Superoxide Production by Inhibiting Protein Kinase C: Potential Clinical Implications in Hypertension

G. Zalba, J. López-Sagaseta, J. Hermida, 2009, Hypertension.

sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove.

C. Esmon, J. López-Sagaseta, J. Hermida, 2012, Blood.

Factor X and factor VII binding to endothelial protein C receptor differs between species

J. Hermida, R. Montes, C. Puy, 2011, Journal of thrombosis and haemostasis : JTH.

Recombinant expression of biologically active murine soluble EPCR.

J. López-Sagaseta, J. Hermida, R. Montes, 2009, Protein expression and purification.

Identification and characterization of a natural R96C EPCR variant

H. Philippou, J. Hermida, A. Catto, 2003, Journal of thrombosis and haemostasis : JTH.

Regulation of the antithrombotic activity of the endothelial cell protein C receptor by bioactive lipids

J. López-Sagaseta, J. Hermida, R. Montes, 2012 .

The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients

J. Hermida, R. Montes, J. Zozaya, 2008, British journal of haematology.